SPDR S&P Biotech ETF $XBI Stock Sold by Marotta Asset Management

Marotta Asset Management decreased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 57,881 shares of the exchange traded fund’s stock after selling 8,929 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.5% of Marotta Asset Management’s investment portfolio, making the stock its 25th largest holding. Marotta Asset Management owned 0.09% of SPDR S&P Biotech ETF worth $9,127,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Axiom Investment Management LLC purchased a new stake in SPDR S&P Biotech ETF during the first quarter valued at about $26,000. Financial Life Planners purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter worth approximately $27,000. Angeles Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $28,000. SHP Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $31,000. Finally, Greykasell Wealth Strategies Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $35,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded down $0.08 during mid-day trading on Friday, hitting $154.43. The stock had a trading volume of 8,742,205 shares, compared to its average volume of 9,099,798. The company’s 50 day moving average is $158.24 and its 200-day moving average is $144.85. SPDR S&P Biotech ETF has a 12-month low of $102.55 and a 12-month high of $169.89. The company has a market cap of $10.22 billion, a PE ratio of 11.47 and a beta of 0.84.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.